Comparison

G-418 (disulfate) European Partner

Item no. HY-17561-500mg
Manufacturer MedChem Express
CASRN 108321-42-2
Amount 500 mg
Quantity options 10 mM/1 mL 1 g 500 mg 5 g
Category
Type Inhibitors
Specific against other
Purity 99.75
Citations [1]Giordano-Santini R, et al. An antibiotic selection marker for nematode transgenesis. Nat Methods. 2010;7(9):721-723.|[2]Volarevic M, et al. A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicity. Bioconjug Chem. 2007;18(6):1965-1971.|[3]Kwon KM, et al. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells. Int J Biol Sci. 2017;13(3):265-275. Published 2017 Feb 12.|[4]Davies J, et al. A new selective agent for eukaryotic cloning vectors. Am J Trop Med Hyg. 1980;29(5 Suppl):1089-1092.
Adv Healthc Mater. 2025 Mar 4:e2404501.|Adv Sci (Weinh). 2025 Feb 11:e2404961.|Am J Cancer Res. 2021 May 15;11(5):2062-2080.|BMC Complement Med Ther. 2024 Nov 16;24(1):400.|Cancer Commun (Lond). 2022 Nov 9.|Cancer Res. 2023 Feb 6;CAN-22-3169.|Cell Death Differ. 2020 Jun;27(6):1981-1997.|Cell Death Dis. 2020 Jun 4;11(6):420.|Cell Death Dis. 2019 May 28;10(6):413.|Cell Rep. 2020 Oct 20;33(3):108287.|Cell Rep. 2021 Mar 30;34(13):108906.|Cell Rep. 2021 Sep 21;36(12):109739.|Cell Rep. 2022 Oct 25;41(4):111561.|Chemosphere. 2024 Sep 24:143350.|Emerg Microbes Infect. 2023 Sep 19;2261556.|Environ Toxicol. 2024 Jul 2.|Eur J Pharmacol. 2025 Feb 22:177418.|Hum Cell. 2022 Jul 6.|J Agric Food Chem. 2022 Apr 6;70(13):3989-3999.|J Biol Chem. 2023 Mar 17;104621.|J Cell Mol Med. 2023 Mar 13.|J Genet Genomics. 2021 Mar 30.|Life Sci. 2024 Jun 1:346:122626.|Med Oncol. 2021 Nov 10;39(1):10.|Mol Cell. 2023 Nov 20:S1097-2765(23)00914-0.|Nature. 2023 Jun;618(7966):862-870.|Oxid Med Cell Longev. 2022 Jan 28;2022:8168988.|Patent. US20240299557A1.|Protein Cell. 2025 Feb 18:pwaf014.|Research Square Preprint. 2020 Jun.|Research Square Preprint. 2021 Nov.|Research Square Print. 2023 Feb 21.|Sci Adv. 2024 Aug 16;10(33):eado1533.|Theranostics. 2022 Jan 1;12(3):1187-1203.|Transl Cancer Res. 2023 Jan 23; 12(1):150-162.|Acta Pharmacol Sin. 2023 May 16.|Cell Mol Biol Lett. 2024 Feb 17;29(1):26.|FASEB J. 2023 Nov;37(11):e23195.|Research Square Preprint. 2023 Jul 11.|SSRN. 2024 Jun 19.
Smiles O=S(O)(O)=O.O[C@@H]([C@@H]1O[C@@]([C@@H]([C@@H](O)[C@@H]2O)N)([H])O[C@]2([H])[C@H](O)C)[C@H]([C@@H](C[C@@H]1N)N)O[C@](OC[C@](C)(O)[C@@H]3NC)([H])[C@@H]3O.O=S(O)(O)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Geneticin sulfate,Antibiotic G-418 sulfate
Shipping Condition Room temperature
Available
Manufacturer - Type
Natural Products
Manufacturer - Targets
Antibiotic; Bacterial
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen, away from moisture)
Molecular Weight
692.71
Product Description
G-418 disulfate (Geneticin sulfate), is an aminoglycoside antibiotic, inhibits protein synthesis in eukaryotes and prokaryotes. G-418 disulfate is commonly used as a selective agent for eukaryotic cells[1].
Manufacturer - Research Area
Infection
Solubility
H2O: 125 mg/mL (ultrasonic)
Manufacturer - Pathway
Anti-infection
Isoform
Aminoglycoside
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close